Cargando…
KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer
Lung cancer is one of the most common malignancy worldwide and causes estimated 1.6 million deaths each year. Cancer immunosurveillance has been found to play an important role in lung cancer and may be related with its prognosis. KLRK1, encoding NKG2D, is a homodimeric lectin-like receptor. However...
Autores principales: | Zhang, Yanan, Chen, Zeyang, Jiang, Aifang, Gao, Guanqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821622/ https://www.ncbi.nlm.nih.gov/pubmed/35132098 http://dx.doi.org/10.1038/s41598-022-05997-z |
Ejemplares similares
-
Involvement of KLRK1 in immune infiltration of head and neck squamous cell carcinoma correlates with favorable prognosis
por: Tan, Haosheng, et al.
Publicado: (2023) -
Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2
por: Tsyklauri, Oksana, et al.
Publicado: (2023) -
The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy
por: Zhang, Yanan, et al.
Publicado: (2021) -
EFCC1 as a putative prognostic biomarker in lung adenocarcinoma
por: Yu, Shengnan, et al.
Publicado: (2020) -
SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma
por: Zhang, Weiguo, et al.
Publicado: (2018)